Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   CEPS(Rs) 54.1464.41109.0565.0351.71

What is the latest Cash Earnings per Share (CEPS) ratio of AUROBINDO PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of AUROBINDO PHARMA is 54.14 based on Mar2023 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202354.14
Mar202264.41
Mar2021109.05
Mar202065.03
Mar201951.71

How is Cash Earnings per Share (CEPS) of AUROBINDO PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2023 54.14
-15.94
Mar2022 64.41
-40.94
Mar2021 109.05
67.69
Mar2020 65.03
25.76
Mar2019 51.71 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,140.2 Cr 1% 5.7% 86.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,026.0 Cr 0.5% -5.7% 55.1% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.4% 55.5% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -0.7% 9.4% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 0.1% 1.1% 28.1% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 6% 2.8% 93.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1%

5.7%

86.4%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses